METROPOLITAN LIFE INSURANCE CO/NY - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 178 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,761
-36.2%
4,3410.0%0.00%0.0%
Q2 2023$21,575
+0.6%
4,3410.0%0.00%0.0%
Q1 2023$21,445
-40.4%
4,341
-24.1%
0.00%
-50.0%
Q4 2022$35,973
-24.9%
5,719
+29.0%
0.00%0.0%
Q3 2022$47,876
-5.3%
4,4330.0%0.00%0.0%
Q2 2022$50,536
+25.1%
4,4330.0%0.00%
+100.0%
Q1 2022$40,385
-84.9%
4,433
-75.3%
0.00%
-75.0%
Q4 2021$267,277
-45.4%
17,914
-6.0%
0.00%
-42.9%
Q3 2021$489,585
-1.5%
19,0500.0%0.01%0.0%
Q2 2021$496,824
-8.4%
19,050
+24.0%
0.01%
-12.5%
Q1 2021$542,349
+35.7%
15,364
-2.9%
0.01%
+33.3%
Q4 2020$399,524
-32.1%
15,829
+1.5%
0.01%
-40.0%
Q3 2020$588,125
-7.7%
15,596
+4.8%
0.01%
-9.1%
Q2 2020$637,376
+151.6%
14,885
+14.2%
0.01%
+120.0%
Q1 2020$253,284
-25.2%
13,0290.0%0.01%
-16.7%
Q4 2019$338,493
-4.7%
13,0290.0%0.01%0.0%
Q3 2019$355,105
+32.4%
13,029
+30.4%
0.01%
+20.0%
Q2 2019$268,204
+5.9%
9,989
+14.0%
0.01%0.0%
Q1 2019$253,309
+1.6%
8,762
-5.3%
0.01%0.0%
Q4 2018$249,2379,2550.01%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders